Medicure Inc V.MPH

Alternate Symbol(s): MCUJF

Healthcare Biotechnology

Medicure Inc. is a pharmaceutical company. It is focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market. The focus of it is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through the Company's United States subsidiary, Medicure Pharma Inc. It also operates Marley Drug Inc. (Marley Drug), a pharmacy subsidiary servicing all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving access to medication for all Americans together with exceptional customer service and free home delivery. AGGRASTAT is indicated to reduce the rate of thrombotic cardiovascular events in patients with non-ST elevation acute coronary syndrome. It also develops pyridoxal 5'-phosphate analogues (P5P Analogues), the processes for their preparation, compositions containing P5P Analogues.

TSXV:MPH - Post by User

Medicure Inc

Bullboard Posts

Comment by whippeton Jan 12, 2005 2:06pm

141 Views

Post# 8420441

RE: some people are selling ...

Summertoy, why would you be disapointed if we saw a deal before conclusion on the phase II? our main problem is that people dont seem to care about the technology we own. This deal would confirm and help improve what the company is working on because of more resources involved, etc. Dont forget, the "deal" you talk about would be for only one product getting developped. This would permit management to focus on more applications and also develop new products sleeping in the pipeline. I would welcome the news of a deal before results of the phase II are in... I'm sure management is taking that situation into account. Have a good day

Bullboard Posts

From now on, dynaCERT instead of Bitcoin or NVIDIA?